Top Markets
#1 Islamic Coin Islamic Coin +155.84%
#2 Siren Siren +36.10%
#3 Arowana Arowana +20.58%
#4 Venom Venom +18.87%
#5 Nockchain Nockchain +17.99%
#6 Cysic Cysic +16.60%
#7 OpenEden OpenEden +16.13%
#8 RedStone RedStone +14.00%
#9 KUB Coin KUB Coin +12.65%
#10 Perle Perle +11.66%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Polyrizon Ltd. Polyrizon Ltd.

Polyrizon Ltd.

PLRZ
Rank in Stocks #31772
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of... Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Share Price
$10.81
Last synced: 2026-08-17
Market Cap
$12.11M
Change (1 day)
-1.55%
Change (1 year)
74.92%
Country
IL
Trade Polyrizon Ltd. (PLRZ)

Category

Healthcare
Earnings for Polyrizon Ltd. (PLRZ)
Earnings in 2026 TTM: 0
According to Polyrizon Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Polyrizon Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR